Toshikazu Ito Selected Research

ErbB Receptors (EGF Receptor)

9/2011

Phase I study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshikazu Ito Research Topics

Disease

11	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2010
6	Neoplasms (Cancer) 01/2018 - 12/2005
3	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2006
2	Bacteremia 03/2024 - 07/2023
2	Body Weight (Weight, Body) 12/2021 - 12/2005
2	Colonic Neoplasms (Colon Cancer) 12/2005 - 11/2004
1	Infections 07/2023
1	Kyphosis 03/2022
1	Pulmonary Hypertension 11/2021
1	Hypoxia (Hypoxemia) 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Febrile Neutropenia 11/2020
1	Liver Diseases (Liver Disease) 01/2018
1	Femoral Fractures (Femoral Fracture) 01/2018
1	Fibroma (Fibromatosis) 05/2016
1	Aggressive Fibromatosis (Desmoid) 05/2016
1	Neutropenia 07/2014
1	Diarrhea 07/2014
1	Pain (Aches) 05/2014
1	Bone Fractures (Bone Fracture) 06/2010
1	Rheumatoid Arthritis 11/2006
1	Colorectal Neoplasms (Colorectal Cancer) 07/2006
1	Carcinoma (Carcinomatosis) 02/2006
1	Pruritus (Itching) 12/2005
1	Cecal Neoplasms 12/2005
1	Anorexia 12/2005
1	Adenocarcinoma 12/2005
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2005
1	Stomach Neoplasms (Stomach Cancer) 11/2004
1	Hepatocellular Carcinoma (Hepatoma) 09/2004
1	Cholangiocarcinoma 01/2003
1	Liver Failure 01/2003

Drug/Important Bio-Agent (IBA)

4	Leucovorin (Folinic Acid)FDA Link 07/2008 - 11/2004
3	TegafurIBA 01/2018 - 12/2005
3	Trastuzumab (Herceptin)FDA Link 01/2018 - 09/2011
3	UracilIBA 01/2018 - 12/2005
3	Fluorouracil (Carac)FDA LinkGeneric 07/2008 - 11/2004
2	Third Generation CephalosporinsIBA 03/2024 - 07/2023
2	Hormones (Hormone)IBA 01/2022 - 06/2010
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2018 - 06/2010
2	SonazoidIBA 08/2017 - 04/2012
2	Contrast MediaIBA 08/2017 - 09/2004
1	CopperIBA 12/2021
1	ZincIBA 12/2021
1	Cilostazol (Pletal)FDA LinkGeneric 11/2021
1	MonocrotalineIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	Docetaxel (Taxotere)FDA Link 11/2020
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Zoledronic Acid (Zometa)FDA Link 01/2018
1	Denosumab FDA Link 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Threonine (L-Threonine)FDA Link 05/2016
1	beta CateninIBA 05/2016
1	Alanine (L-Alanine)FDA Link 05/2016
1	Alanine Transaminase (SGPT)IBA 07/2014
1	Epidermal Growth Factor (EGF)IBA 07/2014
1	perfluorobutane (AI 700)IBA 04/2012
1	ErbB Receptors (EGF Receptor)IBA 09/2011
1	Aromatase InhibitorsIBA 06/2010
1	Tamoxifen FDA LinkGeneric 06/2010
1	AA amyloidosisIBA 11/2006
1	PolymersIBA 02/2006
1	ferric oxide (iron oxide)IBA 02/2006
1	Epirubicin (Ellence)FDA LinkGeneric 02/2006
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2006
1	Imatinib Mesylate (Gleevec)FDA Link 12/2005
1	X 50IBA 12/2005
1	Galactose (Galactopyranose)FDA LinkGeneric 09/2004

Therapy/Procedure

7	Therapeutics 03/2024 - 11/2004
6	Drug Therapy (Chemotherapy) 11/2020 - 12/2005
2	Length of Stay 03/2024 - 01/2003
2	Adjuvant Chemotherapy 07/2006 - 12/2005
1	Mastectomy (Mammectomy) 01/2023
1	Myocutaneous Flap 01/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 03/2022
1	Early Ambulation 01/2021
1	Retreatment 01/2018
1	Intramedullary Fracture Fixation 01/2018
1	Neoadjuvant Therapy 01/2018
1	Activities of Daily Living (ADL) 01/2018
1	Radiofrequency Ablation 01/2018
1	Ultrasonic Therapy 05/2014
1	Microspheres (Microsphere) 02/2006
1	Pancreaticoduodenectomy 02/2006
1	Colectomy 12/2005
1	Lymph Node Excision (Lymph Node Dissection) 12/2005
1	Radiotherapy 12/2005
1	Gastrectomy 11/2004
1	Hepatectomy 01/2003